DFDA

Dexamethasone

Treatment for Cysticercosis

Typical Dosage: 0.1 mg/kg/day (e.g., 4-8mg daily)

Effectiveness
75%
Safety Score
50%
Clinical Trials
5
Participants
20K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Dosage Range
0.1 mg/kg/day (e.g., 4-8mg daily)
Time to Effect
Hours to days
Treatment Duration
1-3 weeks (tapering)
Evidence Quality
HIGH
Number Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
70(Treat 70 patients to see 1 additional serious adverse event)
Confidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$10
Monitoring:$50
Side Effect Mgmt:$70
Total Annual:$130
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$144.4
Dexamethasone Outcomes

for Cysticercosis

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+90%
Common Side Effects
Insomnia
+15%
Mood Changes
+10%
Increased Appetite
+15%
Fluid Retention
+8%
Hyperglycemia
+7%

Sources:

nih.gov
researchgate.net
dntb.gov.ua

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Dexamethasone in Cysticercosis

Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis

NCT06376396NOT YET RECRUITINGPHASE4
View Study
300 participants
INTERVENTIONAL
Started: Jun 1, 2024
Completed Clinical Trials
2 completed trials for Dexamethasone in Cysticercosis

Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis

NCT00004403COMPLETEDNA
View Study
120 participants
INTERVENTIONAL
Started: May 1, 2000

Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients

NCT00290823COMPLETEDPHASE3
View Study
110 participants
INTERVENTIONAL
Lima, Peru
Started: Apr 1, 2006